LAJOLLA
Exhibit 10.1
LAJOLLA
PHARMACEUTICAL COMPANY
VIA FACSIMILE AND EMAIL March 3, 2010
Adamis Pharmaceutical Corporation
0000 Xxx Xxx Xxxxxxx Xxxx, #000
Del Mar, California 92014
Attention: President
Dear Xxxxxx:
This letter is to confirm our agreement today to terminate the Agreement and Plan of Reorganization among La Jolla Pharmaceutical Company, Jewel Merger Sub, Inc., and Adamis Pharmaceutical Corporation, dated December 4, 2009. We regret that we have been unable to obtain the approvals needed to consummate the merger and
appreciate your efforts and investments made in pursuit of this transaction. Upon termination, neither party shall have any obligations, financial or otherwise, to the other party.
We wish you the best in your endeavors.
|
|
|
|
Sincerely, | |
|
/s/ Xxxxxxx X. Xxxxxxxxx, X.X. | |
|
Xxxxxxx X. Xxxxxxxxx, X.X. | |
|
Chief Executive Officer |
Xxxxxx and Acknowledged as of March 3, 2010 Adamis Pharmaceutical Corporation
|
|
By: |
/s/ Xxxxxx Xxxxx, Ph.D. |
Xxxxxx Xxxxxx, Ph.D.
Chief Executive Officer
cc: Xxxxx Xxxxx, Esq.
0000 Xxxxx Xxxxx Xxxxx • San Diego, California 92121 • Phone 000-000-0000 • Fax 000-000-0000
xxx.xxxx.xxx
